GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » Cyclically Adjusted Book per Share

CollPlant Biotechnologies (CollPlant Biotechnologies) Cyclically Adjusted Book per Share : $2.22 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

CollPlant Biotechnologies's adjusted book value per share for the three months ended in Mar. 2024 was $2.134. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.22 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-06), CollPlant Biotechnologies's current stock price is $5.2986. CollPlant Biotechnologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $2.22. CollPlant Biotechnologies's Cyclically Adjusted PB Ratio of today is 2.39.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of CollPlant Biotechnologies was 3.01. The lowest was 2.30. And the median was 2.52.


CollPlant Biotechnologies Cyclically Adjusted Book per Share Historical Data

The historical data trend for CollPlant Biotechnologies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Cyclically Adjusted Book per Share Chart

CollPlant Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.12

CollPlant Biotechnologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.12 2.12 2.22

Competitive Comparison of CollPlant Biotechnologies's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, CollPlant Biotechnologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CollPlant Biotechnologies's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Cyclically Adjusted PB Ratio falls into.



CollPlant Biotechnologies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CollPlant Biotechnologies's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.134/131.7762*131.7762
=2.134

Current CPI (Mar. 2024) = 131.7762.

CollPlant Biotechnologies Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 2.284 99.070 3.038
201503 0.000 99.621 0.000
201506 1.347 100.684 1.763
201509 2.170 100.392 2.848
201512 1.410 99.792 1.862
201603 1.625 100.470 2.131
201606 1.983 101.688 2.570
201609 1.433 101.861 1.854
201612 0.621 101.863 0.803
201703 0.938 102.862 1.202
201706 0.550 103.349 0.701
201709 0.205 104.136 0.259
201712 0.783 104.011 0.992
201803 1.456 105.290 1.822
201806 1.009 106.317 1.251
201809 0.976 106.507 1.208
201812 1.421 105.998 1.767
201903 0.813 107.251 0.999
201906 0.479 108.070 0.584
201909 -0.255 108.329 -0.310
201912 0.721 108.420 0.876
202003 1.125 108.902 1.361
202006 0.893 108.767 1.082
202009 1.046 109.815 1.255
202012 0.643 109.897 0.771
202103 5.108 111.754 6.023
202106 4.819 114.631 5.540
202109 4.534 115.734 5.162
202112 4.189 117.630 4.693
202203 3.896 121.301 4.232
202206 3.563 125.017 3.756
202209 3.230 125.227 3.399
202212 2.886 125.222 3.037
202303 2.625 127.348 2.716
202306 3.160 128.729 3.235
202309 2.829 129.860 2.871
202312 2.475 129.419 2.520
202403 2.134 131.776 2.134

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


CollPlant Biotechnologies  (NAS:CLGN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CollPlant Biotechnologies's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5.2986/2.22
=2.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of CollPlant Biotechnologies was 3.01. The lowest was 2.30. And the median was 2.52.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


CollPlant Biotechnologies Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Traded in Other Exchanges
Address
4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.

CollPlant Biotechnologies (CollPlant Biotechnologies) Headlines

From GuruFocus